(Q49027654)

17 February 2018

title

Brain activation following peripheral administration of the GLP-1 receptor agonist exendin-4. (English)

1 reference

17 February 2018

author name string

Elena-Dana Baraboi

1

1 reference

17 February 2018

David H St-Pierre

2

1 reference

17 February 2018

Julie Shooner

3

1 reference

17 February 2018

Elena Timofeeva

4

1 reference

17 February 2018

Denis Richard

5

1 reference

17 February 2018

publication date

20 July 2011

1 reference

17 February 2018

American Journal of Physiology - Regulatory, Integrative and Comparative Physiology

published in

1 reference

17 February 2018

volume

301

1 reference

17 February 2018

issue

4

1 reference

17 February 2018

page(s)

R1011-24

1 reference

17 February 2018

The inhibitory effects of peripheral administration of peptide YY(3-36) and glucagon-like peptide-1 on food intake are attenuated by ablation of the vagal-brainstem-hypothalamic pathway

cites work

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00424.2010

Hyperglycemia after protein ingestion concurrent with injection of a GLP-1 receptor agonist in rats: a possible role for dietary peptides

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00424.2010

Oxyntomodulin and glucagon-like peptide-1 differentially regulate murine food intake and energy expenditure.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00424.2010

A recombinant human glucagon-like peptide (GLP)-1-albumin protein (albugon) mimics peptidergic activation of GLP-1 receptor-dependent pathways coupled with satiety, gastrointestinal motility, and glucose homeostasis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00424.2010

Lesions of area postrema and subfornical organ alter exendin-4-induced brain activation without preventing the hypophagic effect of the GLP-1 receptor agonist

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00424.2010

Hepatic-portal vein infusions of glucagon-like peptide-1 reduce meal size and increase c-Fos expression in the nucleus tractus solitarii, area postrema and central nucleus of the amygdala in rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00424.2010

Effects of exenatide (exendin-4) on glycemic control and weight over 30 weeks in metformin-treated patients with type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00424.2010

Biologic actions and therapeutic potential of the proglucagon-derived peptides

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00424.2010

Lesions of the central nucleus of the amygdala. I: Effects on taste reactivity, taste aversion learning and sodium appetite.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00424.2010

Vasorelaxant effect of glucagon-like peptide-(7-36)amide and amylin on the pulmonary circulation of the rat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00424.2010

Glucagon-like peptide-1: a potent regulator of food intake in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00424.2010

High doses of vasopressin delay the onset of extinction and strengthen acquisition of LiCl-induced conditioned taste avoidance

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00424.2010

Connections of the parabrachial nucleus with the nucleus of the solitary tract and the medullary reticular formation in the rat

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00424.2010

C-fos mRNA pattern and corticotropin-releasing factor neuronal activity throughout the brain of rats injected centrally with a prostaglandin of E2 type.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00424.2010

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00424.2010

Central administration of glucagon-like peptide-1 activates hypothalamic neuroendocrine neurons in the rat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00424.2010

Validation of tests of completeness of vagotomy in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00424.2010

Antiobesity action of peripheral exenatide (exendin-4) in rodents: effects on food intake, body weight, metabolic status and side-effect measures

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00424.2010

Effects of vagotomy with and without pyloroplasty on weight and food intake in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00424.2010

Stimulus-transcription coupling in the nervous system: involvement of the inducible proto-oncogenes fos and jun.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00424.2010

Normalization of fasting hyperglycaemia by exogenous glucagon-like peptide 1 (7-36 amide) in type 2 (non-insulin-dependent) diabetic patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00424.2010

Absence of lithium-induced taste aversion after area postrema lesion.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00424.2010

Peripheral versus central effects of glucagon-like peptide-1 receptor agonists on satiety and body weight loss in Zucker obese rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00424.2010

Comparison of Fos induced in rat brain by GLP-1 and amylin.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00424.2010

Intrameal hepatic portal and intraperitoneal infusions of glucagon-like peptide-1 reduce spontaneous meal size in the rat via different mechanisms

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00424.2010

Expression of c-fos protein in brain: metabolic mapping at the cellular level

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00424.2010

Glucagon like peptide-1 (7-36) amide (GLP-1) nerve terminals densely innervate corticotropin-releasing hormone neurons in the hypothalamic paraventricular nucleus

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00424.2010

Acute effects of glucagon-like peptide-1 on hypothalamic neuropeptide and AMP activated kinase expression in fasted rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00424.2010

Effects of central and basolateral amygdala lesions on conditioned taste aversion and latent inhibition.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00424.2010

Peripheral exendin-4 and peptide YY(3-36) synergistically reduce food intake through different mechanisms in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00424.2010

Role of central glucagon-like peptide-1 in hypothalamo-pituitary-adrenocortical facilitation following chronic stress

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00424.2010

Contribution of the vagus nerve and lamina terminalis to brain activation induced by refeeding.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00424.2010

Effects of treadmill running on brain activation and the corticotropin-releasing hormone system.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00424.2010

Neuronal activation and corticotropin-releasing hormone expression in the brain of obese (fa/fa) and lean (fa/?) Zucker rats in response to refeeding

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00424.2010

A role for glucagon-like peptide-1 in the central regulation of feeding

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00424.2010

The inhibitory effect of glucagon-like peptide-1 (GLP-1) 7-36 amide on gastric acid secretion in humans depends on an intact vagal innervation

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00424.2010

Leptin regulation of the anorexic response to glucagon-like peptide-1 receptor stimulation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00424.2010

Glucagon-like peptide-1 receptor stimulation increases blood pressure and heart rate and activates autonomic regulatory neurons

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00424.2010

Brain regions responsible for the expression of conditioned taste aversion in rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00424.2010

Glucose-lowering and insulin-sensitizing actions of exendin-4: studies in obese diabetic (ob/ob, db/db) mice, diabetic fatty Zucker rats, and diabetic rhesus monkeys (Macaca mulatta).

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00424.2010

Antihypertensive effect of glucagon-like peptide 1 in Dahl salt-sensitive rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00424.2010

Ibotenic acid lesions of the parabrachial nucleus and conditioned taste aversion: further evidence for an associative deficit in rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00424.2010

10.1152/AJPREGU.00424.2010

21 January 2018

Identifiers

DOI

1 reference

17 February 2018

PubMed ID

21775649

1 reference

17 February 2018